Glucocorticoid_NN
receptor_NN
in_IN
patients_NNS
with_IN
lupus_NN
nephritis_NN
:_:
relationship_NN
between_IN
receptor_NN
levels_NNS
in_IN
mononuclear_JJ
leukocytes_NNS
and_CC
effect_NN
of_IN
glucocorticoid_NN
therapy_NN
._.

We_PRP
investigated_VBD
the_DT
clinical_JJ
significance_NN
of_IN
glucocorticoid_NN
receptor_NN
determination_NN
in_IN
20_CD
patients_NNS
with_IN
systemic_JJ
lupus_NN
erythematosus_NN
-LRB-_-LRB-
SLE_NN
-RRB-_-RRB-
who_WP
afterwards_RB
developed_VBD
nephrotic_JJ
syndrome_NN
._.

Glucocorticoid_NN
receptor_NN
concentrations_NNS
in_IN
mononuclear_JJ
leukocytes_NNS
-LRB-_-LRB-
MNL_NN
-RRB-_-RRB-
in_IN
these_DT
patients_NNS
were_VBD
comparable_JJ
with_IN
those_DT
in_IN
both_DT
other_JJ
patients_NNS
with_IN
SLE_NN
and_CC
healthy_JJ
persons_NNS
._.

Improvement_NN
in_IN
urinary_JJ
protein_NN
excretion_NN
and_CC
in_IN
disease_NN
activity_NN
,_,
which_WDT
was_VBD
scored_VBN
according_VBG
to_TO
the_DT
SLE_NNP
Disease_NNP
Activity_NNP
Index_NNP
system_NN
of_IN
the_DT
University_NN
of_IN
Toronto_NNP
,_,
closely_RB
related_JJ
to_TO
the_DT
glucocorticoid_NN
receptor_NN
concentrations_NNS
in_IN
MNL_NN
isolated_VBN
from_IN
the_DT
corresponding_JJ
patients_NNS
._.

In_IN
summary_NN
,_,
glucocorticoid_NN
receptor_NN
determination_NN
in_IN
patients_NNS
with_IN
lupus_NN
nephritis_NN
may_MD
be_VB
a_DT
predictive_JJ
clue_NN
for_IN
assessing_VBG
responsiveness_NN
to_TO
glucocorticoid_NN
therapy_NN
._.

